Experience with the use of azacitidine in patients with low-risk myelodysplastic syndrome

被引：0
|
作者：
Duarte, F. [1 ]
Santos, T. [1 ]
Barbosa, M. [1 ]
Santos, T. [1 ]
Goncalves, R. [1 ]
机构：
[1] Univ Fed Ceara, Dept Hematol Transplant, Fortaleza, Ceara, Brazil
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70366-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-319
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] EXPERIENCE WITH THE USE OF 5-AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW/INTERMEDIATE RISK
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Perez Dolores, Subira
    Maqueda Cristina, Fernandez
    Ramo Alejandro, Vazquez
    Martin Sonia, Herrero
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 152 - 152
  • [2] Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine
    Daitoku, Shinya
    Aoyagi, Tomomi
    Takao, Shinichiro
    Tada, Seiya
    Kuroiwa, Mika
    INTERNAL MEDICINE, 2018, 57 (20) : 2995 - 2999
  • [3] The role of rHuEpo in low-risk myelodysplastic syndrome patients
    Rigolin, GM
    Castoldi, G
    LEUKEMIA & LYMPHOMA, 2005, 46 (06) : 823 - 831
  • [4] Interim analysis of phase II randomized trial of azacitidine versus support treatment in patients with low-risk myelodysplastic syndrome
    Sanchez-Garcia, J.
    Falantes, J.
    Medina, A.
    Hernandez-Mohedo, F.
    Torres-Sabariego, A.
    Hermosin, L.
    Bailen, A.
    Sole, M.
    Casano, J.
    Calderon, C.
    Vahi, M.
    Serrano, J.
    LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [5] Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
    Pappa, V.
    Papageorgiou, S.
    Tsirigotis, P.
    Dervenoulas, J.
    Girkas, K.
    Papageorgiou, E.
    Poulakidas, H.
    Papadaki, E.
    Galanopoulos, A.
    Vervessou, E.
    Panayotidis, P.
    Zomas, A.
    Symeonidis, A.
    Economopoulos, T.
    LEUKEMIA RESEARCH, 2009, 33 : S134 - S135
  • [6] Leukaemia cutis in a patient with low-risk myelodysplastic syndrome
    Lin, Jinran
    Zhang, Qiao'an
    Chen, Minghua
    JOURNAL OF DERMATOLOGY, 2010, 37 : 42 - 42
  • [7] Past, present and future in low-risk myelodysplastic syndrome
    Toprak, Selami Kocak
    FRONTIERS IN MEDICINE, 2022, 9
  • [8] Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome
    Park, Songyi
    Shin, Dong-Yeop
    Park, Junseo Steve
    Park, Hee Sue
    Moon, Soo Young
    Yoon, Sung-Soo
    Lee, Dong-Soon
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [9] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Eric J. Feldman
    Current Hematologic Malignancy Reports, 2011, 6 : 1 - 2
  • [10] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Feldman, Eric J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 1 - 2
12345